CDI Seminar: “CD147-CAR-NK for Solid Tumor Treatment and Immunological Synapse Application”

Title: “CD147-CAR-NK for Solid Tumor Treatment and Immunological Synapse Application”

Speaker:
Dongfang Liu, PhD
Associate Professor with Tenure
Director of the Immunoassay Development Program, Department of Pathology, Immunology, and Laboratory Medicine
Rutgers University – New Jersey Medical School (NJMS)

Location:
Via Zoom (Meeting ID: 85182977937)

About the Speaker:

Dongfang Liu, PhD, is an associate professor with tenure and the director of the Immunoassay Development Program at the Department of Pathology, Immunology, and Laboratory Medicine at Rutgers University – New Jersey Medical School (NJMS). He also serves as the scientific director of the Cellular Imaging & Histology Core at Rutgers-NJMS. Dr. Liu earned his PhD from 2001 to 2005 and completed postdoctoral training from 2005 to 2011, specializing in the immunobiology of natural killer (NK) cells. He joined the National Institutes of Health (NIH) for his postdoctoral training in 2005. After completing his postdoctoral training at NIH, he joined the Ragon Institute of MGH, MIT, and Harvard in 2011 as a Senior Research Scientist, focusing on HIV-specific immune cell dysfunction. Dr. Liu’s current research focuses on the immunobiology of NK cells, chimeric antigen receptor (CAR)-NK cells, and immune synapse biology and application. With over 20 years of experience in NK cell research and more than 10 patent applications, Dr. Liu has published extensively in top-tier journals, including Nature Immunology, Immunity, Nature Communications, JACI, and the Proceedings of the National Academy of Sciences (PNAS). He serves on several editorial boards and acts as a reviewer for numerous journals and grant agencies, including the NIH. Dr. Liu holds multiple federal research grants to study the basic mechanisms of NK cell biology and CAR-NK.

Host:
Dr. David Perlin